Evidence map›Paper›PMID 40830322›Full record

ReviewCurrent oncology reports2025

The Role of Integrative Oncology in Patients Affected by Triple Negative Breast Cancer.

Shlomit Ein Gal, Samuel Mathis, Bhavana Pathak, Moshe Frenkel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shlomit Ein GalUniversity of Vermont Breast Oncology Unit, Burlington, VT, USA.
Samuel MathisDepartment of Family Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Bhavana PathakIntegrative Oncology at Saddleback Medical Center, MemorialCare Cancer Institute, Laguna-Hills, CA, USA.
Moshe FrenkelDepartment of Family Medicine, University of Texas Medical Branch, Galveston, TX, USA. frenkelm@netvision.net.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review examines the unmet needs of patients with triple-negative breast cancer (TNBC), the limitations of current treatment approaches, and the role of integrative modalities in symptom management, patient care, and quality-of-life enhancement. Despite advances in oncology, TNBC remains a clinical challenge due to its aggressive nature, intensive treatments, and disparities in access to care, leading to variable outcomes. This review summarizes recent progress in integrative oncology and its potential benefits for TNBC patients. RECENT

findingsTNBC patients face significant physical and psychosocial challenges, compounded by disparities in treatment and supportive care access. Continuous chemotherapy-based regimens often lead to accumulating symptoms, highlighting the need for integrative approaches. Evidence suggests that modalities such as nutritional counseling, physical activity programs, mind-body interventions (e.g., mindfulness, yoga) acupuncture and certain herbal remedies can help alleviate symptoms, improve well-being, and enhance resilience. A growing body of evidence supports the integration of these approaches into TNBC care to improve quality of life. The Society for Integrative Oncology has issued clinical practice guidelines recommending these modalities, yet challenges remain in optimizing personalized approaches and ensuring equitable access. Future research should focus on refining integrative strategies and increasing awareness of their benefits for TNBC patients.

Indexed as

Integrative OncologyTriple Negative Breast NeoplasmsFemaleHumansQuality of LifeCancer careIntegrative oncologyPatient centered careSupportive careTriple negative breast cancer, complementary medicine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.